Some four years ago the aminoacid dimethylcysteine (penicillamine) was introduced into clinical medicine as a chelating agent1, 2 and the time is now ripe to review what is known of the chemistry, pharmacology and therapeutic action of this compound.
It was a result of urgent war time research into the chemistry of the penicillins that led to the discovery of a new aminoacid which received its name, penicillamine, from the parent compound.3 Some years later it was shown to be a sulphur aminoacid structurally related to cysteine, but differing from it by the addition of two methyl groups to the
PENICILLAMINE: THE PHARMACOLOGY OF A CHELATING AGENT(PENICILLAMINE: THE PHARMACOLOGY OF A CHELATING AGENT*). Ann Intern Med. 1960;53:1090–1096. doi: 10.7326/0003-4819-53-5-1090
Download citation file:
Published: Ann Intern Med. 1960;53(5):1090-1096.
Results provided by:
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use